Irene Chang Britt - Sep 1, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Irene Chang Britt
Stock symbol
IDXX
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4
Date filed
9/6/2023, 05:00 PM
Previous filing
Jul 21, 2023
Next filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Award $0 +208 $0.00 208 Sep 1, 2023 Common Stock 208 Direct F1, F2
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +493 $0.00 493 Sep 1, 2023 Common Stock 493 $511.29 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from her election to the IDEXX Laboratories, Inc. Board of Directors on July 11, 2023 until the 2024 annual meeting of stockholders.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in one installment on the date of the 2024 annual meeting of stockholders or May 17, 2024, whichever event occurs earlier.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 17, 2024 or on the date of the 2024 annual meeting of stockholders, whichever event is earlier.